What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original can be viewed in PDF format using the link above.

The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet is: EU/1/04/306/001 .

Aloxi 250 micrograms solution for injection

Package leaflet: Information for the user

Aloxi 250 micrograms solution for injection

Palonosetron

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others.
  • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1. What Aloxi is and what it is used for
2. What you need to know before you are given Aloxi
3. How you are given Aloxi
4. Possible side effects
5. How to store Aloxi
6. Contents of the pack and other information

1. What Aloxi is and what it is used for

Aloxi contains the active substance palonosetron. This belongs to a group of medicines called ‘serotonin (5HT3) antagonists’.

Aloxi is used in adults, adolescents and children over one month of age to help stop you feeling or being sick (nausea and vomiting) when having cancer treatments called chemotherapy.

It works by blocking the action of a chemical called serotonin, which can cause you to feel sick or to vomit.

2. What you need to know before you are given Aloxi

Do not take Aloxi if:

  • you are allergic to palonosetron or any of the other ingredients of this medicine (listed in section 6).

You will not be given Aloxi if any of the above apply to you. If you are not sure, talk to your doctor or nurse before you are given this medicine.

Warnings and precautions

Talk to your doctor or nurse before you are given Aloxi if:

  • you have a blocked bowel or have had repeated constipation in the past
  • you have had heart problems or heart problems run in your family, such as changes in your heart beat (‘QT prolongation’)
  • you have an imbalance of certain minerals in your blood which has not been treated - such as potassium and magnesium.

If any of the above applies to you (or you are not sure), talk to your doctor or nurse before you are given Aloxi.

Other medicines and Aloxi

Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines. In particular, tell them if you are taking the following medicines:

Medicines for depression or anxiety

Tell your doctor or nurse if you are taking any medicines for depression or anxiety, including:

  • medicines called SSRIs (‘selective serotonin reuptake inhibitors’) – such as fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram
  • medicines called SNRIs (‘serotonin noradrenaline reuptake inhibitors’) – such as venlafaxine, duloxetine (can lead to the development of serotonin syndrome and should be used with caution).

Medicines that can affect your heart beat

Tell your doctor or nurse if you are taking any medicines that affect your heart beat – this is because they could cause a heart beat problem when taken with Aloxi. This includes:

  • medicines for heart problems such as amiodarone, nicardipine, quinidine
  • medicines for infections such as moxifloxacin, erythromycin
  • medicines for serious mental health problems such as haloperidol, chlorpromazine, quetiapine, thioridazine
  • a medicine for feeling or being sick (nausea and vomiting) called domperidone.

If any of the above applies to you (or you are not sure), talk to your doctor or nurse before taking Aloxi – this is because these medicines could cause a heart beat problem when taken with Aloxi.

Pregnancy

If you are pregnant or think you might be pregnant, your doctor will not give you Aloxi unless it is clearly necessary. This is because we do not know if Aloxi may harm the baby.

Ask your doctor or nurse for advice before being given this medicine if you are pregnant or think you might be.

Breast-feeding

It is not known if Aloxi is found in breast milk.

Ask your doctor or nurse for advice before being given this medicine if you are breast-feeding.

Driving and using machines

You may feel dizzy or tired after being given this medicine. If this happens, do not drive or use any tools or machines.

Aloxi contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium- free’.

3. How you are given Aloxi

Aloxi is normally given by a doctor or nurse.

  • You will be given the medicine about 30 minutes before the start of chemotherapy.

Adults

  • The recommended dose of Aloxi is 250 micrograms.
  • It is given as an injection into a vein.

Children and young people (aged 1 month to 17 years)

  • The doctor will work out the right dose based on bodyweight.
  • The maximum dose is 1500 micrograms.
  • Aloxi will be given as a drip (a slow infusion into a vein).

It is not recommended you are given Aloxi in the days following chemotherapy unless you are going to have another chemotherapy cycle.

If you have any further questions on the use of this medicine, ask your doctor or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects may happen with this medicine:

Serious side effects

Tell your doctor straight away if you notice any of the following serious side effects:

  • allergic reaction - the signs may include swelling of the lips, face, tongue or throat, having difficulty breathing or collapsing, an itchy, lumpy rash (hives). This is very rare: may affect up to 1 in 10,000 people.

Tell your doctor straight away if you notice any of the serious side effects listed above.

Other side effects

Tell your doctor if you notice any of the following side effects:

Adults

Common: may affect up to 1 in 10 people

  • headache, feeling dizzy,
  • constipation, diarrhoea.

Uncommon: may affect up to 1 in 100 people

  • change in the colour of the vein and veins becoming larger
  • feeling happier than usual or feeling anxious
  • feeling sleepy or trouble sleeping
  • decrease or loss of appetite
  • weakness, feeling tired, fever or flu like symptoms
  • numbness, burning, prickling or tingling sensations on the skin
  • itchy skin rash
  • impaired vision or eye irritation
  • motion sickness
  • ringing in the ear
  • hiccups, passing wind (flatulence), dry mouth or indigestion
  • abdominal (stomach) pain
  • difficulty passing water (urinating)
  • joint pain.

Tell your doctor if you notice any of the side effects listed above.

Uncommon side effects shown in tests: may affect up to 1 in 100 people

  • high or low blood pressure
  • abnormal heart rate or lack of blood flow to the heart
  • abnormally high or low levels of potassium in the blood
  • high levels of sugar in the blood or sugar in the urine
  • low levels of calcium in the blood
  • high levels of the pigment bilirubin in the blood
  • high levels of certain liver enzymes
  • ECG (electrocardiogram) abnormalities (‘QT prolongation’).

Very rare: may affect up to 1 in 10,000 people

  • Burning, pain or redness at the injection site

Children and young people

Common: may affect up to 1 in 10 people

  • headache.

Uncommon: may affect up to 1 in 100 people

  • dizziness
  • jerky body movements
  • abnormal heart rate
  • coughing or shortness of breath
  • nosebleed
  • itchy skin rash or hives
  • fever
  • pain at the site of infusion.

Tell your doctor if you notice any of the side effects listed above.

Reporting of side effects

If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom:

Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard

Ireland:

HPRA Pharmacovigilance
Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517
Website: www.hpra.ie

or

E-mail: [email protected]

5. How to store Aloxi

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the vial and carton after ‘EXP’. The expiry date refers to the last day of that month.
  • This medicine does not require any special storage conditions.
  • Single use only, any unused solution should be disposed of.

6. Contents of the pack and other information

What Aloxi contains

  • The active substance is palonosetron (as hydrochloride). Each ml of solution contains 50 micrograms palonosetron. Each vial of 5 ml of solution contains 250 micrograms of palonosetron.
  • The other ingredients are mannitol, disodium edetate, sodium citrate, citric acid monohydrate, water for injections, sodium hydroxide and hydrochloric acid.

What Aloxi looks like and contents of the pack

Aloxi solution for injection is a clear, colourless solution and is supplied in a pack of one Type I glass vial with chlorobutyl siliconised rubber stopper and aluminium cap, which contains 5 ml of the solution. Each vial contains one dose.

Available in packs of 1 vial containing 5 ml of solution.

Marketing Authorisation Holder and Manufacturer

Helsinn Birex Pharmaceuticals Ltd.
Damastown
Mulhuddart
Dublin 15
Ireland

This leaflet was last revised in 04/2018

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu